Advertisement

Virchows Archiv

, Volume 475, Issue 4, pp 519–525 | Cite as

SOX11 expression in a case of papillary thyroid carcinoma with fibromatosis/fasciitis-like stroma containing BRAF c.1799_1801delTGA and CTNNB1 c.133T>C mutations

  • Soon Boon Justin Wong
  • Min En Nga
  • Michal Michal
  • Tomas Vanecek
  • Ju Ee Seet
  • Fredrik PeterssonEmail author
Brief Report
  • 73 Downloads

Abstract

We describe a case of papillary thyroid carcinoma with fibromatosis/fasciitis-like stroma (PTC-FLS) that contained the rare BRAF c.1799_1801delTGA (p.V600_K601delinsE) mutation, which has not previously been reported in this tumour, as well as the CTNNB1 c.133T>C (p.S45P) mutation. We also report the novel observation that spindle cells of the mesenchymal component exhibit diffuse nuclear but not cytoplasmic expression of SOX11, whereas the malignant epithelial cells did not. This suggests that immunoreactivity for SOX11 can be an alternative diagnostic tool for evaluating cases of PTC-FLS where the nuclear expression of β-catenin is ambiguous.

Keywords

Papillary thyroid carcinoma Fibromatosis/fasciitis-like stroma SOX11 β-Catenin BRAF Mutation 

Notes

Authors’ contributions

SBJW: tissue sampling, histological analysis, interpretation of data, literature review, drafting and review of manuscript. MEN: histological analysis, interpretation of data and review of manuscript. TV and MM: analysis of molecular features. JES: cytological analysis and review of manuscript. FP: histological analysis, interpretation of data, literature review, review of manuscript, study supervision, study design, decision to submit and publish the manuscript. All authors gave the final approval for publication.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

This is a brief report on a novel and unique case of diagnostic interest; it is not a research project; there is no human or animal participant(s). It is our institution’s policy not to require consent for studies up to two subjects.

References

  1. 1.
    Barollo S, Pezzani R, Cristiani A, Redaelli M, Zambonin L, Rubin B, Bertazza L, Zane M, Mucignat-Caretta C, Bulfone A, Pennelli G, Casal Ide E, Pelizzo MR, Mantero F, Moro S, Mian C (2014) Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations. Thyroid 24:809–819.  https://doi.org/10.1089/thy.2013.0403 CrossRefPubMedGoogle Scholar
  2. 2.
    Ginter PS, Scognamiglio T (2015) Papillary thyroid carcinoma with nodular fasciitis-like stroma: a usual entity with distinctive morphology. Int J Surg Pathol 23:305–307.  https://doi.org/10.1177/1066896915570362 CrossRefPubMedGoogle Scholar
  3. 3.
    Goh X, Lum J, Yang SP, Chionh SB, Koay E, Chiu L, Parameswaran R, Ngiam KY, Loh TKS, Nga ME, Lim CM (2019) BRAF mutation in papillary thyroid cancer-prevalence and clinical correlation in a South-East Asian cohort. Clin Otolaryngol 44:114–123.  https://doi.org/10.1111/coa.13238 CrossRefPubMedGoogle Scholar
  4. 4.
    Hou P, Liu D, Xing M (2007) Functional characterization of the T1799-1801del and A1799-1816ins BRAF mutations in papillary thyroid cancer. Cell Cycle 6:377–379.  https://doi.org/10.4161/cc.6.3.3818 CrossRefPubMedGoogle Scholar
  5. 5.
    Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173:1518–1527.  https://doi.org/10.2353/ajpath.2008.080475 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I, Coindre J-M (2012) CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol 25:1551–1558.  https://doi.org/10.1038/modpathol.2012.115 CrossRefPubMedGoogle Scholar
  7. 7.
    Misemer BS, Skubitz AP, Carlos Manivel J, Schmechel SC, Cheng EY, Henriksen JC, Koopmeiners JS, Corless CL, Skubitz KM (2014) Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Med 3:81–90.  https://doi.org/10.1002/cam4.160 CrossRefPubMedGoogle Scholar
  8. 8.
    Na KY, Kim HS, Sung JY, Park WS, Kim YW (2013) Papillary carcinoma of the thyroid gland with nodular fasciitis-like stroma. Kor J Pathol 47:167–171.  https://doi.org/10.4132/KoreanJPathol.2013.47.2.167 CrossRefGoogle Scholar
  9. 9.
    Ostrowski MA, Moffat FL, Asa SL, Rostein LE, Chamberlain D (1989) Myxomatous change in papillary carcinoma of the thyroid. Surg Pathol 2:249–256Google Scholar
  10. 10.
    Rebecchini C, Nobile A, Piana S, Sarro R, Bisig B, Gerasimos SP, Saglietti C, Matter M, Marino L, Bongiovanni M (2017) Papillary thyroid carcinoma with nodular fasciitis-like stroma and beta-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosis. Mod Pathol 30:236–245.  https://doi.org/10.1038/modpathol.2016.173 CrossRefPubMedGoogle Scholar
  11. 11.
    Skubitz KM (2017) Biology and treatment of aggressive fibromatosis or desmoid tumor. Mayo Clin Proc 92:947–964.  https://doi.org/10.1016/j.mayocp.2017.02.012 CrossRefPubMedGoogle Scholar
  12. 12.
    Takada N, Hirokawa M, Ito M, Ito A, Suzuki A, Higuchi M, Kuma S, Hayashi T, Kishikawa M, Horikawa S, Miyauchi A (2017) Papillary thyroid carcinoma with desmoid-type fibromatosis: a clinical, pathological, and immunohistochemical study of 14 cases. Endocr J 64:1017–1023.  https://doi.org/10.1507/endocrj.EJ17-0242 CrossRefPubMedGoogle Scholar
  13. 13.
    Takada N, Mussazhanova Z, Hirokawa M, Nakashima M, Miyauchi A (2018) Immunohistochemical and molecular analyses focusing on mesenchymal cells in papillary thyroid carcinoma with desmoid-type fibromatosis. Pathobiology 85:300–303.  https://doi.org/10.1159/000492117 CrossRefPubMedGoogle Scholar
  14. 14.
    Tarabichi M, Antoniou A, Le Pennec S, Gacquer D, de Saint AN, Craciun L, Cielen T, Laios I, Larsimont D, Andry G, Dumont JE, Maenhaut C, Detours V (2018) Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers. J Clin Endocrinol Metab 103:1102–1111.  https://doi.org/10.1210/jc.2017-02279 CrossRefPubMedGoogle Scholar
  15. 15.
    Zhou L, Shi L, Jiang Z, Xie L (2018) Papillary thyroid carcinoma with nodular-fasciitis-like stroma and beta-catenin gene mutations: report of a recurrent case. Int J Clin Exp Pathol 11:2879–2883Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Soon Boon Justin Wong
    • 1
    • 2
  • Min En Nga
    • 1
  • Michal Michal
    • 3
  • Tomas Vanecek
    • 4
  • Ju Ee Seet
    • 5
  • Fredrik Petersson
    • 1
    • 5
    Email author
  1. 1.Department of PathologyNational University HospitalSingaporeSingapore
  2. 2.Department of Microbiology and ImmunologyNational University of SingaporeSingaporeSingapore
  3. 3.Department of Pathology, Faculty of Medicine in PlzenCharles UniversityPlzenCzech Republic
  4. 4.Molecular and Genetic LaboratoryBiopticka Laboratory Ltd.PlzenCzech Republic
  5. 5.Department of PathologyNational University Health SystemSingaporeSingapore

Personalised recommendations